Gema Biotech S.A.

Quick facts

Phase 3 pipeline

• FOLITIME®
  FOLITIME® is a folate metabolism modulator designed to enhance cellular folate availability and support DNA synthesis and cell division.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Gema Biotech S.A. portfolio CI brief
• Gema Biotech S.A. pipeline updates RSS